NANETS Regional NET Education: The Multidisciplinary Management of NET Disease

Saturday, November 11, 2023

7:00am – 4:40pm 

Earn up to 6.75 AMA PRA Category 1 Credits,™ Continuing Nursing Education (ANCC), and MOC accreditation

Register Now


The Henry, Autograph Collection
300 Town Center Drive,
Dearborn, Michigan 48126


Jointly Provided by Henry Ford Health, Wayne State University School of Medicine and the North American Neuroendocrine Tumor Society

Course Directors

Philip A Philip, MD, PhD, FRCP, Henry Ford Health, Wayne State University School of Medicine


Neuroendocrine tumors (NET) are considered to be a rare disease although the frequency of diagnosis has increased over the last ten years. As this is a rare disease, clinicians often do not know how to implement the appropriate care plan and until the last ten years, there was great variability in terms of treatment. The diagnosis, treatment, and management of NETs are time-consuming, complex, and require a multidisciplinary approach. Many healthcare providers who face these challenges are not adequately equipped in their knowledge or experience optimally manage NET disease.

The field of NET research has been evolving with new drug approvals and treatment modalities. In addition, experts in the field of NET disease have continued to develop strategies to improve diagnosis, treatment and management of NET cancers. It is through convening professionals in the areas of oncology, gastroenterology, pulmonology, surgery, radiology and allied fields that the awareness and understanding of NET diseases will expand, resulting in better treatment for NET patients.

Target Audience

This activity is designed for oncologists, gastroenterologists, pulmonologists, surgeons, radiologists, pathologists, primary care physicians, advanced practice nurses, nurses, physician assistants, pharmacists, fellows, students, and other allied health professionals involved with or interested in the treatment of patients with neuroendocrine tumors.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Review current concepts of neuroendocrine tumor pathology, molecular profile, classification, and grading
  • Discuss the various diagnostic processes and use of current and emerging diagnostic tools to determine neuroendocrine tumor type
  • Summarize the current safety and efficacy data of the various surgical, medical and loco-regional approaches in the management of neuroendocrine tumors
  • Recognize the clinical features associated with carcinoid syndrome
  • Apply a multidisciplinary approach to the management of patients with neuroendocrine tumors
  • Review clinical trial data and ongoing studies evaluating novel management strategies for the treatment of neuroendocrine tumors


7:00am - 8:00am
8:00am - 8:10am
Registration and Breakfast
Welcome and Opening Remarks
    • Dr. Philip Philip, MD, PhD, FRCP, Henry Ford Health, Wayne State University
8:10am - 8:40am
Pathological Principles of NETs and NECs
    • Brian Theisen, MD, Henry Ford Health
8:40am - 9:10am
Surgical Management of NETS
    • Rupen Shah, MD, Henry Ford Health
9:10am - 9:50am
Medical Management of NETS (excluding PRRT)
    • Amr Mohamed, MD, UH Seidman Cancer Center, University Hospital
9:50am - 10:05am

Audience Participation
10:05am - 10:30am Break

10:30am - 11:00am
Emerging Genetic Syndromes and the Value of Genetic Testing
    • Nancie Petrucelli, MS, CGC, Karmanos Cancer Institute
11:00am - 11:30am
Liver Artery Directed Therapies 
    • Jeffery Critchfield, MD, FSIR, Karmanos Cancer Institute
11:30am - 12:00pm
Managing NET in the Liver
    • Steve Kim, MD, Karmanos Cancer Institute
12:00pm - 12:15pm

Audience Participation
12:15pm - 12:45pm

12:45pm - 1:15pm
Tumor Genomics in NETS
    • Maria Diab, MD, Henry Ford Health
1:15pm - 1:45pm
Liver and Multivisceral Transplantation
    • Shunji Nagai, MD, Henry Ford Health
1:45pm - 2:15pm
PRRT and Newer Emitters
    • Jonathan Strosberg, MD, Moffitt Cancer Center
2:15pm - 2:35pm

Audience Participation
2:35pm - 2:50pm

2:50pm - 3:20pm
Functional Imaging of NETS
    • Kevin O'Brien, MD, Henry Ford Health
3:20pm - 3:50pm
Management of the Carcinoid Syndrome
    • Gazala Khan, MD, Henry Ford Health
3:50pm - 4:20pm
    • Dipesh Uprety, MD, Karmanos Cancer Institute
4:20pm - 4:35pm

Audience Participation
4:35pm - 4:40pm
Closing Remarks
    • Dr. Philip Philip, MD, PhD, FRCP, Henry Ford Health, Wayne State University

Register Now


This continuing education activity is provided through collaboration between the North American Endocrine Tumor Society (NANETS) and AffinityCE. This activity provides continuing education credit for physicians, physician assistants, nurse practitioners, and nurses. A statement of participation is available for other attendees.

Physicians, Physician Assistants, and Nurse Practitioners

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and the NANETS. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.

AffinityCE designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians for ABIM Maintenance of Certification (MOC)

Successful completion of this CME activity, which includes participation in the evaluation enables the participant to earn up to 6.75 Medical Knowledge only MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program.

It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Use of Learner/Participant Data

Participation information will be shared with the applicable certifying board via ACCME PARS.

In order for MOC credit to be reported, evaluations must be completed prior to the close of evaluations.


Continuing Nursing Education is provided for this program through the joint providership of AffinityCE and NANETS. AffinityCE is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC). This activity provides a maximum of 6.75 hours of continuing nursing education credit.

Registration fee:


$65 - MD, PharmD, Doctoral Level 
$35 - Allied Health
Complimentary - Student/Fellow/Resident


$95 - MD, PharmD, Doctoral Level 
$50 - Allied Health
Complimentary - Student/Fellow/Resident

Cancellation Policy:

A full refund will be made if registration is canceled, in writing, on or before May 5, 2023. On or after May 6, 2023, no refund will be made.

Sunnybrook Health Sciences Centre, the University of Toronto, and the North American Neuroendocrine Tumor Society reserve the right to modify the activity content, faculty, and activities and reserve the right to cancel this activity if necessary. If the program is canceled, liability is limited to the registration fee.


Please contact us with any questions.